Jason Fredette | Vice President-Investor Relations and Corporate Communications |
Bill Hinshaw | President and Chief Executive Officer |
Laurent Chardonnet | Senior Vice President and Chief Financial Officer |
Margaret Koziel | Vice President-Clinical Development |
Alison Schecter | President-R&D |
Ed Arce | H.C. Wainwright & Company |
Jessica Fye | JPMorgan |
Mayank Mamtani | B. Riley Securities |
Keay Nakae | Chardan |
Andreas Argyrides | Wedbush Securities |
Good morning, ladies and gentlemen, and welcome to Axcella’s Second Quarter 2021 Conference Call. Please be advised that today’s conference is being recorded, and then all participants will be in a listen-only mode until the question-and-answer session. [Operator Instructions] And now for opening remarks, I would now like to hand the call over to Mr. Jason Fredette, Vice President of Investor Relations and Corporate Communications at Axcella. Please go ahead.